YISHENG BIOPHARMA Trademark

Trademark Overview


On Friday, September 17, 2021, a trademark application was filed for YISHENG BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the YISHENG BIOPHARMA trademark a serial number of 79334282. The federal status of this trademark filing is REGISTERED as of Tuesday, April 4, 2023. This trademark is owned by Liaoning Yisheng Bio-Pharmaceutical Co., Ltd.. The YISHENG BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Drugs for medical purpose for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; pharmaceutical preparations for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; vaccines; injectable medical solutions for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; medicines in the form of tablets for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; liquid medicine for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; nasal spray for medical purposes; ointment for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; tumor suppressing agents; immunostimulants; medicines for human use for the prevention an...
yisheng biopharma

General Information


Serial Number79334282
Word MarkYISHENG BIOPHARMA
Filing DateFriday, September 17, 2021
Status700 - REGISTERED
Status DateTuesday, April 4, 2023
Registration Number7014791
Registration DateTuesday, April 4, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "YISHENG BIOPHARMA" in stylized green font.
Goods and ServicesDrugs for medical purpose for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; pharmaceutical preparations for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; vaccines; injectable medical solutions for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; medicines in the form of tablets for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; liquid medicine for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; nasal spray for medical purposes; ointment for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; tumor suppressing agents; immunostimulants; medicines for human use for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases
Indication of Colors claimedThe color(s) green is/are claimed as a feature of the mark.
Translation of Words in MarkThe wording "YISHENG" has no meaning in a foreign language.
Disclaimer with Predetermined Text"BIOPHARMA"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLiaoning Yisheng Bio-Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCN

Party NameLiaoning Yisheng Bio-Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCN

Party NameLiaoning Yisheng Bio-Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCN

Trademark Events


Event DateEvent Description
Tuesday, October 3, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 25, 2023GENERIC MADRID TRANSACTION SENT TO IB
Monday, July 24, 2023GENERIC MADRID TRANSACTION CREATED
Tuesday, July 4, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 4, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, January 25, 2023NOTIFICATION PROCESSED BY IB
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 20, 2022REFUSAL PROCESSED BY IB
Saturday, June 25, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 25, 2022REFUSAL PROCESSED BY MPU
Thursday, June 23, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 22, 2022ASSIGNED TO EXAMINER
Tuesday, March 1, 2022APPLICATION FILING RECEIPT MAILED
Friday, February 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 24, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB